These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23237034)

  • 21. [What is new in the treatment of vitiligo].
    Khaled A; Zeglaoui F; Ezzine N; El Fekih N; Fazaa B; Kamoun MR
    Tunis Med; 2008 Apr; 86(4):307-11. PubMed ID: 19476128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options for palmoplantar pustulosis.
    Adişen E; Gürer MA
    Clin Exp Dermatol; 2010 Apr; 35(3):219-22. PubMed ID: 19874337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.
    Nicolaidou E; Antoniou C; Stratigos A; Katsambas AD
    J Am Acad Dermatol; 2009 Mar; 60(3):470-7. PubMed ID: 19157641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
    Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Advanced Therapeutic Approaches to Treat Vitiligo.
    Sharma CK; Sharma M; Aggarwal B; Sharma V
    J Environ Pathol Toxicol Oncol; 2015; 34(4):321-34. PubMed ID: 26756425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
    Ju HJ; Bae JM
    Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on new and emerging options for the treatment of vitiligo.
    Mahmoud BH; Hexsel CL; Hamzavi IH
    Skin Therapy Lett; 2008 Mar; 13(2):1-6. PubMed ID: 18373041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of phototherapy in the surgical treatment of vitiligo: a systematic review.
    Lommerts JE; Uitentuis SE; Bekkenk MW; de Rie MA; Wolkerstorfer A
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1427-1435. PubMed ID: 29573480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitiligo: an update on systemic treatments.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
    Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
    Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
    Taieb A; Alomar A; Böhm M; Dell'anna ML; De Pase A; Eleftheriadou V; Ezzedine K; Gauthier Y; Gawkrodger DJ; Jouary T; Leone G; Moretti S; Nieuweboer-Krobotova L; Olsson MJ; Parsad D; Passeron T; Tanew A; van der Veen W; van Geel N; Whitton M; Wolkerstorfer A; Picardo M; ; ;
    Br J Dermatol; 2013 Jan; 168(1):5-19. PubMed ID: 22860621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Association of targeted intense pulse light system UVA1-UVB and fluticasone in the treatment of vitiligo: Prospective study of 10 patients.
    Coelho JD; Ferreira A
    Dermatol Online J; 2010 Mar; 16(3):15. PubMed ID: 20233572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
    Scherschun L; Kim JJ; Lim HW
    J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of home-based phototherapy for vitiligo: A systematic review of randomised controlled trials.
    Ashraf AZ; Azurdia RM; Cohen SN
    Photodermatol Photoimmunol Photomed; 2022 Sep; 38(5):409-417. PubMed ID: 34967477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.